Stock analysts at StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of Sorrento Therapeutics stock opened at $0.01 on Friday. Sorrento Therapeutics has a one year low of $0.00 and a one year high of $0.25. The business’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01.
About Sorrento Therapeutics
See Also
- Five stocks we like better than Sorrento Therapeutics
- How to Most Effectively Use the MarketBeat Earnings Screener
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 9/16 – 9/20
- Insider Trading – What You Need to Know
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.